Related Experiment Videos
The process chain for peptidomic biomarker discovery.
Michael Schrader1, Hartmut Selle
1Department of Biotechnology and Bioinformatics, University of Applied Sciences, Weihenstephan, D-85350 Freising, Germany. michael.schrader@fh-weihenste
Disease Markers
|January 18, 2006
Summary
Peptidomics, the study of peptides, offers a new avenue for discovering diagnostic biomarkers. This approach enhances medical treatment and accelerates drug development by analyzing molecular processes in diseases.
Area of Science:
- Biochemistry
- Proteomics
- Biomarker Discovery
Background:
- Increasing demand for specific and sensitive diagnostic markers.
- Need for improved differentiation of disease types and stages.
- Peptides are crucial in physiological processes and drug research.
Purpose of the Study:
- Present concepts for using peptidomics technologies for biomarker discovery.
- Illustrate the application of peptidomics in biomarker identification.
- Highlight the potential of peptide biomarkers in clinical studies.
Main Methods:
- Adaptation of proteomic technologies for peptide analysis.
- Development of a new peptidomic technology platform.
- Comprehensive analysis of peptides and small proteins (peptidomics).
Main Results:
- Exploration of endogenous peptides can lead to new drug substances and biomarker candidates.
- Peptidomics addresses a gap in comprehensive proteomic analysis.
- Study design and data interpretation are crucial for significant results.
Conclusions:
- Peptidomics holds potential for discovering novel peptide biomarkers.
- Identified biomarker candidates require validation in further studies.
- This approach can significantly improve clinical studies and patient outcomes.